Dimitrios Bafaloukos
- Oncology top 0.5%
- Pulmonary and Respiratory Medicine top 1%
- Molecular Biology top 10%
- Cancer Research top 2%
- Surgery top 5%
- Co-authors
- P. KosmidisHelena LinardouSamuel MurrayIssa J DahabrehGeorge FountzilasHelen GogasChristos PapadimitriouDimitrios Pectasides
- Topics
- Cancer Treatment and Pharmacology (35 papers)HER2/EGFR in Cancer Research (28 papers)Breast Cancer Treatment Studies (26 papers)
- Partner nations
- GreeceUnited StatesGermany
In The Last Decade
Dimitrios Bafaloukos
126 papers receiving 4.4k citations
Hit Papers
Peers
Comparison fields: 5 of 104
- Oncology 3.0k
- Pulmonary and Respiratory Medicine 1.6k
- Molecular Biology 1.2k
- Cancer Research 867
- Surgery 585
Countries citing papers authored by Dimitrios Bafaloukos
This map shows the geographic impact of Dimitrios Bafaloukos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dimitrios Bafaloukos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dimitrios Bafaloukos more than expected).
Fields of papers citing papers by Dimitrios Bafaloukos
This network shows the impact of papers produced by Dimitrios Bafaloukos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dimitrios Bafaloukos. The network helps show where Dimitrios Bafaloukos may publish in the future.
Co-authorship network of co-authors of Dimitrios Bafaloukos
This figure shows the co-authorship network connecting the top 25 collaborators of Dimitrios Bafaloukos. A scholar is included among the top collaborators of Dimitrios Bafaloukos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dimitrios Bafaloukos. Dimitrios Bafaloukos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 15 | |
| 2 | 8 | |
| 3 | 6 | |
| 4 | 8 | |
| 5 | 12 | |
| 6 | Prognostic Significance of VEGFC and VEGFR1 mRNA Expression According to HER2 Status in Breast Cancer: A Study of Primary Tumors from Patients with High-risk Early Breast Cancer Participating in a Randomized Hellenic Cooperative Oncology Group Trial. | 6 |
| 7 | 15 | |
| 8 | 11 | |
| 9 | 137 | |
| 10 | 116 | |
| 11 | 428 | |
| 12 | 22 | |
| 13 | 13 | |
| 14 | 1 | |
| 15 | 6 | |
| 16 | 26 | |
| 17 | Bone metastases from malignant melanoma: a retrospective review and analysis of 28 cases | 12 |
| 18 | 10 | |
| 19 | 28 | |
| 20 | 9 |
About Dimitrios Bafaloukos
Dimitrios Bafaloukos is a scholar working on Oncology, Cancer Research and Reproductive Medicine, having authored 132 papers that have together received 4.5k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (35 papers), HER2/EGFR in Cancer Research (28 papers) and Breast Cancer Treatment Studies (26 papers). The work is most often cited by research in Oncology (3.0k citations), Cancer Research (867 citations) and Pulmonary and Respiratory Medicine (1.6k citations). Dimitrios Bafaloukos has collaborated with scholars based in Greece, United States and Germany. Frequent co-authors include P. Kosmidis, Helena Linardou, Samuel Murray, Issa J Dahabreh, George Fountzilas, Helen Gogas, Christos Papadimitriou, Dimitrios Pectasides, Gerasimos Aravantinos and Haralabos P. Kalofonos. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.